Cilazapril
Cilazapril | |
---|---|
IUPAC name (1S,9S)-9-[(2S)-(1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino]-10-oxo-octahydro-1H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid[citation needed] | |
Identifiers | |
CAS number | 88768-40-5 |
PubChem | 56330, 40467985 (1R,9S)-(2S)-butylamino isomer |
ChemSpider | 50831 |
UNII | 8Q9454114Q |
DrugBank | DB01340 |
KEGG | D07699 |
ChEMBL | CHEMBL515606 |
ATC code | C09 |
Jmol-3D images | Image 1 |
| |
| |
Properties | |
Molecular formula | C22H31N3O5 |
Molar mass | 417.50 g mol−1 |
log P | 2.212 |
Acidity (pKa) | 2.285 |
Basicity (pKb) | 11.712 |
Pharmacology | |
Routes of administration |
Oral |
Legal status |
POM(UK) |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
Cilazapril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure.[1][2] It is branded as Inhibace in Canada and other countries, Vascace and Dynorm in a number of European countries, among many other names. None of these are available in the United States as of May 2010.[3]
Of the eight possible stereoisomers, only the all-S form is medically viable.[citation needed]
References
- Cilazapril monograph. Lexi-Comp Online, Lexi-Drugs Online, Lexi-Comp Inc. Hudson, OH. Available at: . Accessed October 5, 2008.
|